Mather Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
PR
SGH
Mather Group's XBI Position: Q3 2026 in Review
Mather Group reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 73% in Q3 2026, selling an estimated $90K and leaving 206 shares worth $32.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1290.
Mather Group first reported a position in XBI in Q2 2013 and has held it in 13 quarters since. The position peaked at $10.1M in Q4 2013. 235 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Mather Group held 206 shares of State Street SPDR S&P Biotech ETF worth $32.5K as of Q3 2026.
- Mather Group sold 570 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $90K.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1290 holding.
- Mather Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 13 quarters since.
- Mather Group's State Street SPDR S&P Biotech ETF position peaked at $10.1M in Q4 2013.
- 235 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.